Olimpia Meucci
Affiliations: | Drexel University, Philadelphia, PA, United States |
Google:
"Olimpia Meucci"Mean distance: 18.28 (cluster 51)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DiNatale A, Castelli MS, Nash B, et al. (2022) Regulation of Tumor and Metastasis Initiation by Chemokine Receptors. Journal of Cancer. 13: 3160-3176 |
| DiNatale A, Kaur R, Qian C, et al. (2022) Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy. Oncogene |
| Sulzer D, Antonini A, Leta V, et al. (2020) COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. Npj Parkinson's Disease. 6: 18 |
| Festa LK, Irollo E, Platt BJ, et al. (2020) CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility. Elife. 9 |
| Nash B, Festa L, Lin C, et al. (2019) Opioid and Chemokine Regulation of Cortical Synaptodendritic Damage in HIV-Associated Neurocognitive Disorders. Brain Research. 146409 |
| Worrede-Mahdi A, Meucci O, Fatatis A. (2019) Limiting tumor seeding as a therapeutic approach for metastatic disease. Pharmacology & Therapeutics |
| Qian C, Worrede-Mahdi A, Shen F, et al. (2018) Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy. Molecular Cancer Research : McR |
| Qian C, Worrede-Mahdi A, Kaur R, et al. (2018) Abstract 5191: Targeting CX3CR1 Impairs the reseeding and colonization of circulating tumor cells and decelerates metastatic progression Cancer Research. 78: 5191-5191 |
| Kaur R, Qian C, Salvino J, et al. (2018) Abstract 111: The CX3CR1-Fractalkine axis drives both circulating prostate cancer cells and macrophages to the bone metastatic microenvironment Cancer Research. 78: 111-111 |
| Qian C, Worrede-Mahdi A, Shen F, et al. (2018) Abstract B054: Impairing the reseeding of circulating tumor cells decelerates metastatic progression Molecular Cancer Therapeutics. 17 |